FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199463113> ?p ?o ?g. }

• W3199463113 endingPage "e0009596" @default.
• W3199463113 startingPage "e0009596" @default.
• W3199463113 abstract "Guyana is one of four countries in the Latin American Region where lymphatic filariasis (LF) remains endemic. In preparation for the introduction of a new triple drug therapy regimen (ivermectin, diethylcarbamazine, and albendazole (IDA)) in 2019, an acceptability study was embedded within sentinel site mapping in four regions to assess mass drug administration (MDA) coverage and compliance, acceptability, and perceptions about treatment and disease. The results from this survey would inform the rollout of IDA in Guyana in 2019.Data collection for the study occurred in August 2019, using a validated questionnaire administered by trained enumerators. Across all regions, a total of 1,248 participants were sampled by the Filarial Mapping team. Four-hundred and fifty-one participants aged over 18 years were randomly selected for participation in an expanded acceptability questionnaire. All data were captured in Secure Data Kit (SDK).Acceptability was measured using a mean acceptability score. Unadjusted mean scores ranged from 24.6 to 29.3, with 22.5 as the threshold of acceptability. Regional variation occurred across many indicators of interest: self-rated understanding about LF, mechanisms of LF transmission, LF drug safety and history of treatment during MDA. Region IV (Georgetown) recorded higher knowledge about LF, but lower compliance and acceptability. Number of pills was not perceived as a concern.Acceptability of MDA was good across all four regions under study. Results from this study set a baseline level for key indicators and acceptability, from which the acceptability of IDA can be measured. Regional variations across indicators suggest that localized approaches should be considered for social mobilization and MDA delivery to capture these contextual differences." @default.
• W3199463113 created "2021-09-27" @default.
• W3199463113 creator A5002947598 @default.
• W3199463113 creator A5009762440 @default.
• W3199463113 creator A5012144557 @default.
• W3199463113 creator A5024387811 @default.
• W3199463113 creator A5039379046 @default.
• W3199463113 creator A5052566438 @default.
• W3199463113 creator A5057359557 @default.
• W3199463113 creator A5057468067 @default.
• W3199463113 creator A5061610283 @default.
• W3199463113 creator A5083115406 @default.
• W3199463113 creator A5083434101 @default.
• W3199463113 creator A5089783422 @default.
• W3199463113 date "2021-09-20" @default.
• W3199463113 modified "2023-10-02" @default.
• W3199463113 title "Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana" @default.
• W3199463113 cites W1968371014 @default.
• W3199463113 cites W1972838196 @default.
• W3199463113 cites W1986532204 @default.
• W3199463113 cites W1989159294 @default.
• W3199463113 cites W1996825474 @default.
• W3199463113 cites W1998344560 @default.
• W3199463113 cites W2003904220 @default.
• W3199463113 cites W2010359087 @default.
• W3199463113 cites W2014826063 @default.
• W3199463113 cites W2016278466 @default.
• W3199463113 cites W2028785633 @default.
• W3199463113 cites W2031856125 @default.
• W3199463113 cites W2050425502 @default.
• W3199463113 cites W2053499457 @default.
• W3199463113 cites W2092611789 @default.
• W3199463113 cites W2094174441 @default.
• W3199463113 cites W2095237766 @default.
• W3199463113 cites W2111453430 @default.
• W3199463113 cites W2118256986 @default.
• W3199463113 cites W2126926648 @default.
• W3199463113 cites W2127705226 @default.
• W3199463113 cites W2142397178 @default.
• W3199463113 cites W2170134927 @default.
• W3199463113 cites W2263290155 @default.
• W3199463113 cites W2316360711 @default.
• W3199463113 cites W2331464746 @default.
• W3199463113 cites W2547256732 @default.
• W3199463113 cites W2582406074 @default.
• W3199463113 cites W2964088597 @default.
• W3199463113 cites W3120277694 @default.
• W3199463113 cites W4244077120 @default.
• W3199463113 doi "https://doi.org/10.1371/journal.pntd.0009596" @default.
• W3199463113 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8452018" @default.
• W3199463113 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34543269" @default.
• W3199463113 hasPublicationYear "2021" @default.
• W3199463113 type Work @default.
• W3199463113 sameAs 3199463113 @default.
• W3199463113 citedByCount "8" @default.
• W3199463113 countsByYear W31994631132022 @default.
• W3199463113 countsByYear W31994631132023 @default.
• W3199463113 crossrefType "journal-article" @default.
• W3199463113 hasAuthorship W3199463113A5002947598 @default.
• W3199463113 hasAuthorship W3199463113A5009762440 @default.
• W3199463113 hasAuthorship W3199463113A5012144557 @default.
• W3199463113 hasAuthorship W3199463113A5024387811 @default.
• W3199463113 hasAuthorship W3199463113A5039379046 @default.
• W3199463113 hasAuthorship W3199463113A5052566438 @default.
• W3199463113 hasAuthorship W3199463113A5057359557 @default.
• W3199463113 hasAuthorship W3199463113A5057468067 @default.
• W3199463113 hasAuthorship W3199463113A5061610283 @default.
• W3199463113 hasAuthorship W3199463113A5083115406 @default.
• W3199463113 hasAuthorship W3199463113A5083434101 @default.
• W3199463113 hasAuthorship W3199463113A5089783422 @default.
• W3199463113 hasBestOaLocation W31994631131 @default.
• W3199463113 hasConcept C141071460 @default.
• W3199463113 hasConcept C144024400 @default.
• W3199463113 hasConcept C149923435 @default.
• W3199463113 hasConcept C165901193 @default.
• W3199463113 hasConcept C203014093 @default.
• W3199463113 hasConcept C2776158911 @default.
• W3199463113 hasConcept C2777065887 @default.
• W3199463113 hasConcept C2777411658 @default.
• W3199463113 hasConcept C2777499811 @default.
• W3199463113 hasConcept C2777629521 @default.
• W3199463113 hasConcept C2780133432 @default.
• W3199463113 hasConcept C2781413609 @default.
• W3199463113 hasConcept C2908647359 @default.
• W3199463113 hasConcept C42972112 @default.
• W3199463113 hasConcept C512399662 @default.
• W3199463113 hasConcept C71924100 @default.
• W3199463113 hasConcept C81603835 @default.
• W3199463113 hasConcept C98274493 @default.
• W3199463113 hasConcept C99454951 @default.
• W3199463113 hasConceptScore W3199463113C141071460 @default.
• W3199463113 hasConceptScore W3199463113C144024400 @default.
• W3199463113 hasConceptScore W3199463113C149923435 @default.
• W3199463113 hasConceptScore W3199463113C165901193 @default.
• W3199463113 hasConceptScore W3199463113C203014093 @default.
• W3199463113 hasConceptScore W3199463113C2776158911 @default.
• W3199463113 hasConceptScore W3199463113C2777065887 @default.
• W3199463113 hasConceptScore W3199463113C2777411658 @default.

• next